Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity-Reference-Cited by-同舟云学术

Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity

Published:2020-07-30 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Carvalho Katharinne Ingrid Moraes,Coutinho Diego de Sá,Joca Humberto Cavalcante,Miranda Artur Santos,Cruz Jader dos Santos,Silva Emerson Teixeira,Souza Marcus Vinícius Nora,Faria Robson Xavier,Silva Patricia Machado Rodrigues e,Costa Jorge Carlos Santos,Martins Marco Aurélio

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models;Baker;Pulm. Pharmacol. Ther.,2014

2. Positioning new pharmacotherapies for COPD;Barjaktarevic;Int. J. Chron. Obstruct. Pulmon. Dis.,2015

3. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes;Barnes;J. Allergy Clin. Immunol.,2015

4. Neural regulation of airway smooth muscle tone;Canning;Respir. Physiol.,2001

5. Systemic administration of local anesthetic agents to relieve neuropathic pain;Challapalli;Cochrane Database Syst. Rev.,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effects and pharmacokinetics of nebulized lidocaine in healthy horses;Frontiers in Veterinary Science;2022-09-15

2. Pharmacological profiling of JME-173, a novel mexiletine derivative combining dual anti-inflammatory/anti-spasmodic functions and limited action in Na+ channels;European Journal of Pharmacology;2020-10